3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Urinary Tract Infections
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Lymphoma
1
Leukemia
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Herpes Simplex
1
Hemophilia A
1
Hemangioma, Capillary
1
Interventions
Gene Expression Profiling
33
Flow Cytometry
30
Microarray Analysis
22
Polymerase Chain Reaction
21
Reverse Transcriptase Polymerase Chain Reaction
13
Amplified Fragment Length Polymorphism Analysis
11
Cytogenetic Analysis
10
Surveys and Questionnaires
9
DNA Methylation
9
Blotting, Western
9
Psychiatric Rehabilitation
8
Immunologic Techniques
8
Base Sequence
8
In Situ Hybridization, Fluorescence
6
Blood Specimen Collection
6
Interviews as Topic
5
Therapeutics
3
Immunoenzyme Techniques
3
Imatinib Mesylate
3
Gene Rearrangement
3
Watchful Waiting
2
Pharmacogenomic Testing
2
Mental Status and Dementia Tests
2
Mass Spectrometry
2
Genetic Testing
2
Data Collection
2
Dasatinib
2
Counseling
2
Cell Culture Techniques
2
Blotting, Southern
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Leukemia
×
Clozapine
×
Clear all
NCT04074213
2019-08-30
CLOZARIX
University Hospital, Caen
Unknown
1,000,000 enrolled